Post by
fdfd12 on May 09, 2016 7:26am
MT
We will see if MT is smart.
We know he probably has a lowball offer at $40-$45US.
If he has to guide down this week, then he BETTER take that offer.
Guiding down will kill price and in my opinion, will not reach $40US in 52 weeks.
We will find out Friday.
Comment by
Roller007 on May 09, 2016 7:36am
Agree, earning should be fine as telegraphed in the agm, lowering guidance will prove catastrophic to the share price as we saw in Endo pharma's case.
Comment by
fdfd12 on May 09, 2016 7:43am
BUT Earnings may be ahead of schedule BUT, guiding down has nothing to do with earnings. Q1 they may beat but for the whole year, if they guide down, WE ARE DEAD. Then MT, "please take the deal".
Comment by
Lesalpes29 on May 09, 2016 7:44am
Able to predict the sp if Q1 is not where it's supposed to be... You are far away better investior than me. Have a great week
Comment by
Roller007 on May 09, 2016 7:46am
The current SP is reflecting a miss already. Predicting a highly shorted company like Cxr is playing Russian roulette.
Comment by
fdfd12 on May 09, 2016 7:51am
NO ENDP is 3.5X earnings. CXR at 3.5X earnings would be $18US or $24 CAN
Comment by
puma1 on May 09, 2016 7:54am
even if they hit Q1 and hold guidance, they will jump all over the Brexit vote of late June to keep the pressure on the stock.
Comment by
DeltaVega on May 09, 2016 7:45am
Very strange markets. CXR would need not just to meet Q1 Expectations but BEAT both Revenue and Earnings. Hoping for this. 4 days left......GLTA
Comment by
WillyWally on May 09, 2016 7:45am
Lowering guidance won't be catastrophic for MT's paycheque though... Hope for the best, plan for the worse ;-)